drugset / Trial / NCT00883168

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

NCT00883168

Phase 3 Completed 1791 enrolled Meda Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if the combination of two allergy medications (formulated azelastine/fluticasone product)is more effective than placebo or either component medication alone (azelastine or fluticasone).

Timeline

Start
2009-04
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Azelastine Small molecule 548 ug Intranasal
Subject Azelastine Small molecule 548 mg Intranasal
Subject Fluticasone propionate Other / unclassified 200 ug Intranasal